Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 6
108
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and metabolism of a sulphamide NK2 antagonist in rat, dog and human

, , &
Pages 627-642 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

R. Webster, S. Cole, J. Gedge, S. Roffey, D. Walker & W. Wild. (2003) Pharmacokinetics and disposition of a novel NMDA glycine site antagonist (UK-240,455) in rats, dogs and man. Xenobiotica 33:5, pages 541-560.
Read now

Articles from other publishers (13)

Dennis A. SmithKevin Beaumont, Tristan S. Maurer & Li Di. (2018) Clearance in Drug Design. Journal of Medicinal Chemistry 62:5, pages 2245-2255.
Crossref
Dennis A. Smith, Kevin Beaumont, Tristan S. Maurer & Li Di. (2017) Relevance of Half-Life in Drug Design. Journal of Medicinal Chemistry 61:10, pages 4273-4282.
Crossref
Qiming Cao, Jimmy Yu & Des Connell. (2014) New Allometric Scaling Relationships and Applications for Dose and Toxicity Extrapolation. International Journal of Toxicology 33:6, pages 482-489.
Crossref
Alexander V. LyubimovKevin Beaumont. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 26 .
Stuart W. Paine, Karelle Ménochet, Rebecca Denton, Dermot F. McGinnity & Robert J. Riley. (2011) Prediction of Human Renal Clearance from Preclinical Species for a Diverse Set of Drugs That Exhibit Both Active Secretion and Net Reabsorption. Drug Metabolism and Disposition 39:6, pages 1008-1013.
Crossref
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2003) Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state. Journal of Pharmacy and Pharmacology 55:7, pages 939-949.
Crossref
Donald S. Middleton, A. Roderick MacKenzie, Sandra D. Newman, Martin Corless, Andrew Warren, Allan P. Marchington & Barry Jones. (2005) Structure–activity relationships of 1-alkyl-5-(3,4-dichlorophenyl)-5-{2-[3-(substituted)-1-azetidinyl]-ethyl}-2-piperidones. Part 2: Improving oral absorption. Bioorganic & Medicinal Chemistry Letters 15:17, pages 3957-3961.
Crossref
Anthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby & Paul Morgan. (2004) NONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONS. Drug Metabolism and Disposition 32:2, pages 197-204.
Crossref
X. Emonds-Alt. 2004. Tachykinins. Tachykinins 219 244 .
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2003) Prediction of Human Pharmacokinetics from Animal Data and Molecular Structural Parameters using Multivariate Regression Analysis: Oral Clearance. Journal of Pharmaceutical Sciences 92:12, pages 2427-2440.
Crossref
A. Roderick MacKenzieAllan P. MarchingtonDonald S. MiddletonSandra D. NewmanBarry C. Jones. (2002) Structure−Activity Relationships of 1-Alkyl-5-(3,4-dichlorophenyl)- 5-{2-[(3-substituted)-1-azetidinyl]ethyl}-2-piperidones. 1. Selective Antagonists of the Neurokinin-2 Receptor. Journal of Medicinal Chemistry 45:24, pages 5365-5377.
Crossref
Han van de WaterbeemdDennis A. SmithKevin BeaumontDon K. Walker. (2001) Property-Based Design:  Optimization of Drug Absorption and Pharmacokinetics. Journal of Medicinal Chemistry 44:9, pages 1313-1333.
Crossref
Kevin Beaumont, Alison Harper, Dennis A Smith & Joanne Bennett. (2000) The role of P-glycoprotein in determining the oral absorption and clearance of the NK2 antagonist, UK-224,671. European Journal of Pharmaceutical Sciences 12:1, pages 41-50.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.